Improving the Prediction of Cardiac Surgery-Associated Acute Kidney Injury

Area of Science:

• Nephrology
• Cardiology
• Critical Care Medicine

Background:

• Acute kidney injury (AKI) is a severe complication following cardiac surgery, with current prediction models often insufficient, especially for patients with pre-existing kidney issues.
• Accurate prediction of cardiac surgery-associated AKI is crucial for timely intervention and improved patient outcomes.
• Existing clinical risk scores have limitations in identifying patients at high risk for AKI post-cardiac surgery.

Purpose of the Study:

• To identify intraoperative variables that can enhance the predictive performance of the Cleveland Clinic Score (CCS) for cardiac surgery-associated AKI.
• To evaluate the utility of specific intraoperative parameters in improving the accuracy of AKI risk prediction.
• To refine existing models for better identification of patients susceptible to AKI after cardiac procedures.

Main Methods:

• A prospective cohort study involving 289 elective cardiac surgery patients.
• Comparison of the area under the receiver operator characteristic curve (AUC) for a base model (CCS alone) versus models augmented with intraoperative variables.
• Intraoperative variables assessed included mean arterial pressure, hematocrit, procedure duration, blood transfusions, and fluid balance. AKI was defined using KDIGO 2012 criteria.

Main Results:

• The Cleveland Clinic Score (CCS) alone demonstrated an AUC of 0.72 for predicting postoperative AKI.
• Addition of nadir intraoperative hematocrit to the CCS significantly improved predictive accuracy (AUC = 0.78, P = 0.002).
• In patients without pre-existing chronic kidney disease, nadir hematocrit markedly improved CCS performance (AUC from 0.60 to 0.74).

Conclusions:

• Nadir intraoperative hematocrit is a valuable predictor for improving the discrimination of clinical risk scores for acute kidney injury.
• This finding suggests that intraoperative hematocrit levels could serve as a modifiable target for interventions aimed at preventing AKI.
• Enhanced risk stratification using intraoperative hematocrit can potentially lead to more personalized and effective AKI management strategies in cardiac surgery patients.